Completed PHASE2 INTERVENTIONAL 2-arm NCT01212679

Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury

Pilot Study of Intranasal Nerve Growth Factor for Traumatic Brain Injury(TBI)

Sponsor: Jinling Hospital, China

Interventions nerve growth factor nomral saline

Updated 6 times since 2017 Last updated: Oct 30, 2017 Started: Dec 31, 2010 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Traumatic Brain Injury, this trial is completed. The trial is conducted by Jinling Hospital, China and has accumulated 6 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Nov 2017 — Jun 2018 [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Nov 2017 [monthly]

Active Not Recruiting PHASE2

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Jinling Hospital, China

Data source: Jinling Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China